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Molecular signatures of Calpain 10 isoforms sequences, envisage 
functional similarity and therapeutic potential 
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Abstract: Calpain 10 plays a role in insulin secretion, action and susceptibility to type 2 diabetes. The mechanism 
through which it influences the insulin secretion and action is not completely defined. A structural bioinformatics 
approach is applied to envision its mechanism of action using available tools on NCBI (blastp and blastn), EMBL-EBI, 
Ensembl, Swiss Model Repository websites, I-TASSER, PROCHECK program and Discovery Studio software. 
Homology of domain I and II of calpain10 (isoform a) was established with super family cysteine proteinase domains (II 
a and II b, e=1.30e-77, 1.00e-20). Remaining sequences of domain III and T from (isoform a and c) indicated some 
similarity (Avg. e=1.94e-37) to calpain large subunit domain III (PF01067), the isoform g (139 AA) showed similarity 
with a part of catalytic domain of cysteine protease super family (e-value 1.00e-20). Swiss-model repository for 3D 
structures of protein, showed structural resemblance of 29% with 1QXP template of mu-calpain, 27% with 1KFX of m-
calpain and 32% with 2P0R of calpain 9 in complex with leupeptin. Models prepared through I-TASSER confirmed 
through Ramachandran (RC) plots. The calpain 10 isoforms a, c and g show partial structural and functional 
resemblance to m, mu and calpain 9. This information is useful to find new drugs for disease management. 
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Several drugs for the management of diabetes are 
available worldwide, but their effectiveness and 
inconsistency of side effects in >60% of patient 
population is a question, and no perfect remedy to give a 
comprehensive control is present to date. The 
commercially accessible drugs are classified as; Insulin, 
secretagogues, sensitizers, alpha-glucosidase inhibitors 
and peptide analogs (Adams and Norwood 2003, Lebovitz 
2004). They may be used either individually or in 
combination but results are often not promising and 
efficacy varies inpatients. Prolonged use of these drugs 
results in the succession of co-morbidities, which add to 
complications in the disease (Dupree and Meyer 1980). 
 
During past few decades, type II diabetes mellitus has 
attained epidemic levels rapidly due to the life style, 
environmental changes and dietary habits both in 
developed and developing countries. Discovery of a new 
drug is crucial to save the world population against the 
recent epidemic of diabetes and related complications. 
Structural bioinformatics (SBI) is the new field for drug 
designing and assist in the development of new drugs, 
through subsequent steps which start with the 
identification of a target gene, either with the help of 
genome scan or by genetic polymorphisms. Further three 
dimensional structures; conserved domain homology 
analysis; target–ligand binding analysis, protein- protein 
interactions and efficacy of specific protein against the 
target has been incorporated in current technological 
efforts. 
 
Investigation of protein and gene function is a central 
question in molecular biology, biochemistry and genetics. 
Genes evolve from the same ancestral gene therefore 
retain similarity in their function in most of the cases. 
Finding known genes which have sufficient or less 
sequence identity with a query sequence is therefore a 
powerful way for predicting function of unknown 
proteins. In this paper we use computational techniques to 
generate 3D models for calpain 10 isoforms (a, c and g). 
The selected isoforms are reported as major transcripts 
(Horikawa et al, 2000) and major protein bands through 
immuno-blots in our lab (unpublished data). We have 
studied the resources available in database sequences for 
functional prediction on our generated 3D models of 
theses isoforms and hence reporting comparison with 
existing 3D templates. The minor isoforms (b, d, e, f and 
h) of Calpain 10 has already being reported from our lab 
(Saboohi et al, 2013). The modeling of minor isoforms 
was not included as it was beyond the length of this paper. 
The primary information about Calpain 10 protein coding 
gene is located on chromosome 2 at the position of 2q37. 
3. The Gene has official symbol CAPN10, identification 
ID-11132, OMIM-605286, and synonym is KIAA1845. 
Primary source for this gene is Hugo Nomenclature 
Committee (HGNC: 1477). It can be browsed on related 
sites such as Ensembl by typing ENSG00000142330 and 
at Human Protein Reference data base (HPRD: 5595) 
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Changes in expression level of the general calpain family 
members are known to be involved in the development of 
different diseases such as ischemic stroke, traumatic brain 
injury, rheumatoid arthritis, cataract formation, 
Alzheimer’s disease, limb-girdle muscular dystrophy and 
type 2 diabetes mellitus (Hanis et al., 1996, Horikawa 
2006, Horikawa 2005, Horikawa et al., 2003, Horikawa 
2002, Stumvoll et al., 2001, Hung and Wang 2001, 
Horikawa et al., 2000). Calpain 10 isoforms (a, c and g) 
are universally found in all tissues of human body, are 
thought to be involved in calcium activated, non 
lysosomal, neutral, cysteine protease which partially 
proteolyses its substrates resulting in modulation of its 
own activity. 
 
Genetic variation in calpain10 gene has been found 
associated with 3 fold increased risk of type 2 diabetes. 
The severity of disease may vary in different population, 
(Horikawa 2006, Horikawa 2005,Turner et al., 2005, 
Horikawa et al., 2003, Horikawa 2002, Baier et al., 2000, 
Horikawa et al., 2000) according to the expression levels 
of its isoforms which exert their effects on integrated 
metabolism. The direct mechanism of action of calpain 10 
on the glucose metabolism is yet to be explored but 
suggestions of an indirect mechanism of action are 
reported (Saboohi et al., 2013). Its low expression is 
suggested to play integral role in causation of 
hyperglycemic condition. Its high expression has been 
reported in Huntington’s disease, suggesting its possible 
role in neurological pathology (Gafni et al., 2004). 
Therefore predicting its functions by using bioinformatics 
tools is considered a feasible strategy to evaluate it as 
potential therapeutic candidate for better treatment 
modalities in future. This can be verified in wet lab 
experiments especially in diseased animal models or 
human cell lines by balancing the levels of deranged 
isoforms.  
 
MATERIALS AND METHODS 
 
Functional assessment of calpain 10 gene using 
Bioinformatics tools is determined in this study. We have 
used National Center for Biotechnology Information 
(NCBI), Ensembl genome browser and Swiss Model 
Repository Datasets for this study. Ensembl was used to 
search for the nucleotide and peptide sequences of 
different isoforms of the calpain 10 gene. NCBI Basic 
Local Alignment Search Tool (LAST) was used for the 
analysis of nucleotide and peptide sequences according to 
NCBI tutorial, instruction and previously described 
method (Zhang et al., 2000). Advanced  BLAST was used 
for sequence alignment analysis by Align Software 
(Marchler-Bauer et al., 2009). Homologous domain 
analysis was done by NCBI Conserved Domains Software 
(Marchler-Bauer et al., 2011, Marchler-Bauer and Bryant 
2004). Three dimensional structures were predicted for 
calpain 10 isoform a, c and g by depositing protein 
sequences in Swiss-Model Repository, a division of Swiss 
ExPASY- PROSITE on web (Kopp and Schwede 2004a, 
Kiefer et al., 2009) and on I-TASSER server. Quality of 
models was assessed by making RC plots using 
PROCHECK. We selected calpain10 isoform a (version 
NM_023083.2/NP_ 075571.1), as canonical sequence and 
analyzed the variation of sequence and structure among 
isoforms c (NM_023085.3/NP_ 075573.2) and g 
(NM_023089.1). We would like to mention here that 
isoform g records have not found sufficient support of 
being a transcript recently when reviewed, yet we decided 
to involve this in the current study which is likely to 
become a part of other suitable peptide as there is no 
evidence yet if it degrades completely. The following 
tools were applied in the series of analyses presented in 
this paper. 
 
Retrieving information of calpain 10 gene and its 
isoforms (a, c and g) 
We have used Ensembl (http://www.ensembl.org/) to 
retrieve information of calpain10 gene and its isoforms (a, 
c and g). We extracted gene, mRNA and protein 
sequences from this resource. Briefly, Ensembl home 
page was accessed. Then “human” from popular genomes 
option was selected. A new page specifically for human 
genome appeared; CAPN10 for calpain10 gene was 
written in the window and clicked for search. Summary 
results appeared which contained information by feature 
type and by species. The Feature type option provided 
gene, somatic mutation, transcript and variation which 
were available to select in left hand side navigation pane. 
By species option, similar information was also available. 
A new page appeared with a left hand side navigation 
pane which showed gene summary containing links for 
Splice variants, Supporting evidence, Sequence, External 
reference, Regulation, Comparative Genomes, Gene tree, 
Orthologoues, Paralogues, Protein families, Phenotypes, 
genetic variation and gene history. Nucleotide and amino 
acid sequences of calpain 10 gene, mRNA and amino acid 
sequences of its isoforms were obtained from this site.  
 
Nucleotide and protein sequence alignment 
United States National Centre of Biotechnology 
Information (NCBI) data bases were accessed through 
(http://www.ncbi.nlm.nih.gov/). Medical Subject 
Headings (MeSH) was used to search all the medical and 
biological background information about calpain 10 gene 
and its isoforms. We used NCBI blastn for nucleotide and 
blastp for protein sequence alignment. The protein 
sequences of calpain 10 isoforms searched were either 
obtained from Ensemble or from NCBI and analyzed by 
using different tool available on NCBI blast page 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). For analysis, key 
word, calpain 10 was entered in the search window of the 
home page. The available data present in the resource 
appeared in a new window. We have used Align tool for 
multiple alignment of CAPN 10 isoforms. Alignment of 
Bushra Chaudhry et al 
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mRNA and amino acid sequences of calpain 10 isoforms 
were analyzed. The blast nucleotide algorithm (blastn) 
first breaks the query sequence into the short 
subsequences (words) and then identifies the exact 
matches. In contrast standard protein-protein blast (blastp) 
identified a query sequence as well as other similar 
sequences in protein database. Calpain 10 isoform a was 
used as canonical sequence to determine the alignment 
analysis of calpain 10 c and g. We also analyzed 
conserved domains of calpain 10 with other proteins by 
Conserve domain tool in NCBI following already 
reported method.  
 
Protein modeling and structure analysis 
ExPASy-PROSITE (http:// prosite expasy.org/) is an 
exclusive web server for 3D protein modeling and 
structure analysis. 3D structures of calpain.10 isoforms 
were obtained from Swiss-model ExPASy-PROSITE 
(http://swissmodel.expasy.org/workspace) by uploading of 
amino acid sequences of all three isoforms, isoform a 
(Q9HC96-1), isoform c (Q9HC96-3), Isoform g 
(Q9HC96-7) in workplace available on the site. Login ID 
was created on home page of this site. Once registration 
was completed amino acid sequence of a protein were 
uploaded in the specific window. Results of 3-dimentional 
protein structure were received on email. 
 
Further, I-TASSER (Iterative Threading ASSEmbly 
Refinement) is an on line server which uses amino acids 
sequences to predict three D structure models of protein 
molecules. Briefly, login ID was created on I-TASEER 
(Zhang lab.ccmb.med.umich.edu\I-TASEER). Once ID 
was created sequences of the three isoforms were pasted 
individually in the window available on the server and I-
TASEER was run on them. Results generated by the 
server were retrieved by clicking on the link provided by 
I-TASEER via email. To identify conserved domains 
three-D models that were obtained from I-TASEER were 
open as PDB file in Discovery Studio software. Domains 
were identified by high lighting the sequence of only 
those amino acids that comprises conserved domains. The 
software then simultaneously highlights that specific 
sequence on the model  
 
Evaluation and validation of protein model 
The three-D models of isoforms a, c and g that we 
retrieved from I-TASSER were uploaded on PDB sum 
Generate site (http://www.ebi.ac.uk\thornton-srv/database 
Fig. 1: Calpain10 isoforms conserved regions and templates: cd00044: Calpain super family domains IIa and IIb, 
cd00214 calpain_ III: C2 like sub domain III of super family, calpain10 a, c & g coloured boxes: red (Domain I a a1-
41), Blue (Domain II, a.a 40-321), Green (Domain III, a a 322-494), purple and orange (Domain T, a.a 513-654), 
greenish block isoform g (47, specific substituted amino acids). Blue arrows indicate start and end limits of template 
h l i
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/pdbsum/generate) along with the email address. PDB 
sum then performed full structural analysis and provide 
RC plots of the uploaded protein models using 




Nucleotide sequence alignment 
Sequences of calpain 10 isoforms (a, c and g) indicated 
the difference in the structure. Isoform c, 2197 nucleotide 
stretch showed overall 82% (e-value, 0.0) with isoform a 
sequence. Similarity was distributed as 100% identity 
from 1-1464 nucleotides (e-value 0.0) and a 462 
nucleotide sequence stretch gap was found as missing 
nucleotide. While the remaining sequence from 1938-
2662 again showed 100% identity (e-value, 0.0).  
 
The isoform g showed 17% (e-value, 0.0) nucleotides 
similarity with isoform a sequence. It aligned from 1-453 
with 20-472 sequences of form a. Rest of the sequences is 
different from isoform a as well as isoform c. 
 
Protein sequence alignment 
Protein sequence showed similar trend as of nucleotide 
sequence similarity. Taking isoform a (672 amino acids) 
protein as reference and aligning with isoform c (517 
amino acid), showed 91% homology (e-value 0.0) in 
initial 487 amino acids with 0% gap. A stretch of amino 
acids from 428-582 was missing from isoform c and then 
again 65%identity (e-value 8e-52) was found in last 182 
in initial 487 amino acids with 0% gap. A stretch of amino 
acids with 428-582 was missing from isoform c and then 
again 65% identity (evalue 8e-52) was found in last 182 
amino acids with 15% gaps. Isoform g (139 amino acids) 
showed 97% similarity (e-value 3e-53) from 1-97 amino 
acids with isoform a. Amino acids sequence from 93-139 
are found different from isoform a and rest of the peptide 
sequence is missing, Indicating difference of isoform g 
sequences. Isoform g showed the same similarity when 
aligned with isoform c.  
 
Conserved domain analysis 
Search for similar domain architecture for calpain 10a 
(672 amino acids) and those of c and g was performed 
through NCBI conserved domain analysis (Marchler-
Bauer et al., 2009, Marchler-Bauer and Bryant 2004). The 
results are presented in (fig. 1 and fig. 2). 
 
Results indicated that first two domains of isoform a 
(domain I consisted of 32 amino acids & domain II of 270 
amino acids) also present in all the isoforms, hybridized 
 
Fig. 2: 3D model of Calpain 10 a, c and g showing conserved domains. 3D Model was obtained using I-TASSER and 
Conserved regions determined using CDART and were identified on the model using Discovery Studio software. 
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with calpains of calcium dependent cysteine proteinase 
super family domain IIa and IIb. The conserved domain 
length was 315 amino acids (a. a) (2-319 a. a, bit score: 
324.67, e-value: 1.25e-106). These conserved domains 
function broadly in cytoskeleton remodeling processes, 
cell differentiation, apoptosis and signal transduction. 
 
The calpain isoform a, has two more consecutive 
domains, domain III and T domain. Domain III consisted 
of 186 amino acid starting from 304-490 amino acids and 
T domain is of 181 amino acids starting from 491-672 
amino acid, were similar to the super family calpain large 
subunit, domain III (243 a. a, starting from 327-570). This 
domain III is in 80 kDa large subunit, consisted of two 
sub domains which are calmodulin domains involved in 
binding with calcium and activating the domain II to 
make interaction with phospholipids and translocation to 
cytoplasmic/nuclear membranes. Conserved domain 
included sub domain III of typical and atypical calpains. 
The conserved domain length was 150 amino acids (335-
496 a. a, bit-score: 164.39,e-valueof 4.74e-48). The next 
conserved region including domain T was of 150 amino 
acids (512-653 a. a, bit score: 161.70 e-value: 5.45e-47), 
fig. 2a. 
 
The Isoform c contained three domains. First two 
domains were similar to the domains of calcium 
dependent cysteine protease super family. The conserved 
domain length was 315 amino acids (2-319 a. a, bit score: 
321.59, e-value: 2.30e-107) while third domain was 
similar to the C2 like sub domain III, as in isoform a. the 
conserved domain length was 150 amino acids (335-498 
a. a, bit score: 160.93 e-value: 1.37e-47), fig. 2b. 
 
The form g of calpain 10 consisted of a shorter peptide 
(139 amino acids) and a portion of 91 Amino acids 
hybridized with proteolytic domain II of calcium 
dependent cysteine protease super family. The conserved 
domain length was 315, bit score: 105.49, e-values: 8.13e-
29), fig. 2c. 
 
Protein model analysis 
In order to predict the structure and function of these 
isoforms of capain 10, three dimensional structure were 
analyzed by uploading polypeptide sequences of calpain 
10 isoforms a, c and g to Swiss-model repository of 
ExPASy prosite (Kiefer et al., 2009, Kopp and Schwede 
2004a, Kopp and Schwede 2004b).The results indicated 
the hybridization of all three isoforms to its template 
through ExPASy as given below: 
 
Isoform a 
Polypeptide sequence of Isoform a hybridized to three 
different building models (figs. 3-5). A stretch of 5-
499amino acids has been hybridized to 1qxpB 
template.1qxpB is a mu-like calpain and showed 29% 
similarity with it (e-value0.00e-1, QMEAN Z-score-5). 
Another 10-320 amino acid stretch showed 32% 
similarity with2p0r template which is a sequence stretch 
of calpain 9 (e-value 0.00e-1, QMEAN Z-score-4.63). 
Another stretch of 512-649 amino acids was found 27% 
similar with 1kfxL template, a sequence stretch of m-
calpain large subunit (e-value 1.6e-29, QMEAN Z-score-
3.72). The low QMEANZ scores represent either only for 
membrane proteins or indicate models of poor quality 
which generally are expected to reach such scores. 
 
Isoform c 
Polypeptide sequence of isoform c was hybridized with 
two different building models (figs.3-4). A stretch of 2-
503 amino acids was found 28.2% similar to 1qxpB 
template which is a stretch of nucleotides from mu-
calpain (e-value 0.00e-1, QMEAN Z-score-5.47) while 
the other 2-321 amino acid stretch was found 32.4% 
 
Fig. 3: 3D Structure of Calpain 10 (CAPN10) isoform a & c: created from Swiss model-ExPASy 
(http://swissmodel.expasy.org). PDB template 2p0r hybridized 32% and 31.8% with CAPN10 a and c respectively. 
Estimated per-residue inaccuracy visualized using a color gradient from blue (more reliable regions) to red (potentially 
unreliable). 
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similar as 2p0rA template , a part of calpain 9 (e-value 
0.00e-1, QMEAN Z-score-4.48). 
 
Isoform g 
Polypeptide sequence of isoform g was hybridized with 
only one building model (fig. 5). A stretch of 3-137 amino 
acids was found to 26.3% similar as 1kfuL template (e-
value 1.3e-39), which is a part of m-calpain form II while 
similarity with m-calpain form I (1kfxL, e-value 5.7e-
38QMEAN Z-score-5.737) 
 
Validation of protein models 
3D models of calpain 10a, c and g that we salvaged from 
I-TASSER server was evaluated for authentication using 
RC plot. Briefly, about 93.3%, 94.6% and 98.3% residues 
(non-glycine and non-proline) of calpain 10 a, c and g are 
in acceptable regions. The distribution of amino acids 




To envisage calpain 10 possible involvement in disease 
pathogenesis and their possible potential as future drug 
targets, a structural bioinformatics approach was 
attempted in this study. This approach provided useful 
information for their potential to approach new 
developments. The importance of calpain10 involvement 
in the development and etiology of diabetes has increased 
in the last decade. We report computational analysis of 
three isoforms of calpain 10 (a, c and g) in this study. Our 
results predicted the possible functions of (calpain 10a, c 
and g) isoforms are similar to protease domains of three 
family members (mu, m, calpain 9) of calpain 
superfamily. These are involved in pathogenesis of 
diseases. However the expression levels of calpain 10 
isoforms in health and diseases is almost unknown. RNA 
interference assays may help to identify the specific target 
for drug development, avoiding deleterious side effects of 
unspecific protease inhibition.  
 
The isoforms a and c are 82%, while a and g are 17% 
similar to each other in their nucleotide sequences and 
possessed similar pattern in conserve domain homology. 
Conserved domain analysis of isoform a, showed two 
types of proteolytic domains: 1) the first two domains 
belong to the cysteine protease super family, 2) two 
consecutive domains are similar as the C2 like sub 
domain III of superfamily. It is interpreted from the above 
observation that calpain10a, c and g isoforms may have a 
role of cysteine protease because of their domain I & II 
similarity with the protease superfamily domains. Further, 
Domains III and T of calpain 10a have similarity with C2 
like subdomain III of mu-like calpain (calpain1). Calpains 
1 and 2 both have multiple known targets for pathology of 
diseases. 
 
Fig. 4: 3D Structure of Calpain 10 (CAPN10) isoform a & c: created from Swiss model-ExPASy 
(http://swissmodel.expasy.org). PDB template 1qxp hybridized 29% and 28.2% with CAPN10a and c respectively. 
Estimated per-residue inaccuracy visualized using a color gradient from blue (more reliable regions) to red (potentially 
unreliable).  
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The active sites of the proteins depend on the three 
dimensional structure and ionic bonds. Our analysis for 
these three isoforms sequence, through Swiss-model 
repository hybridized with already existing sequences in 
databases which served as templates. The templates were 
experimentally proven peptides and were of four different 
kinds. These were 1qxp (a mu-like calpain), 2p0r 
(structure of human calpain 9 in complex with leupeptin) 
1kfxL (structure of human m-calpain form I) and 1kfuL 
template (a crystal structure of human m-calpain form II). 
Overall sequence identity was not significant as portion of 
the isoform had similarity with templates. 
 
The three isoforms of calpain 10 showed structural 
similarities with the n-terminal end of the members of 
typical calpain family (m, mu and calpain 9). Among 
these, m and mu are the classical members while calpain 
9 is an atypical calpain. This is because of having T-
 
Fig. 5: 3D Structure of Calpain 10 (CAPN10) isoform a: created from Swiss model-ExPASy 
(http://swissmodel.expasy.org). PDB template 1kfxL hybridized 27% with CAPN10a. Estimated per-residue 
inaccuracy visualized using a color gradient from blue (more reliable regions) to red (potentially unreliable). 
 
 
Fig. 6: 3D Structure of Calpain 10 (CAPN10) isoform g created from Swiss model-ExPASy 
(http://swissmodel.expasy.org). PDB template 1kfxL hybridized 26.3% with CAPN10g. Estimated per-residue 
inaccuracy visualized using a color gradient from blue (more reliable regions) to red (potentially unreliable). 
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domain (150 amino acids) which covers 22% of the total 
sequences of the protein. The first 320 amino acids of 
Calpain 10 isoform a showed 32% identity to 2p0r 
template which is a part of calpain 9 and 500 amino acids 
showed 29% sequence identity to the 1qxp template 
which is a portion of mu-calpain. A stretch of (137 amino 
acids) starting from 512-649 amino acids showed 
structural identity of 27% with 1kfxL sequences. The 
protein folding looks quite similar with calpain 9, which 
is involved in causing peptic ulcer. Further, greater than 
50% down regulation have been reported in rats’ heart 
during cardiac hypertrophy.  
 
Conserved domain analysis of this stretch (137 amino 
acids) starting from 512-649 amino acids showed its 
similarity with C2 like subdomain III which plays a key 
role in calcium induced activation of calpain and 
facilitates its interaction with phospholipids resulting in 
translocation to cytoplasmic/ nuclear membrane. Swiss 
repository structural analysis of calpain10c isoform 
showed its similarity with two template peptides, 1qxp 
(mu- calpain) and 2p0r (Calpain 9), which are similar as 
shown by calpain 10a. It lacks the second domain similar 
to C2 like domain III which is present in calpain10a.  
 
Based upon observed homology found with low z scores 
in modeling indicate week representation of the overlay 
functions from domains I, II and III of these three 
isoforms. It was inferred that calpain 10 may have little 
involvement in similar functions under normal 
physiological state. Normal expression and function of 
calpain10 isoforms especially a and c seems essential for 
the normal glucose metabolism and insulin receptor 
activation at times of low calcium availability when m, 
mu and calpain 9 are in repressed condition. Calpain10 is 
also reported to regulate purified protein kinase C activity 
in vitro (Bollag et al., 1986). A lower expression level of 
calpain 10 gene because of variants is consistence with 
insulin levels. This represents its regulatory role in 
pancreatic beta cells for insulin secretion and apoptotic 
activity in these pancreatic cells. This can lead to up 
regulation of protein kinase C activity which directly 
phosphorylate serine residues of insulin receptor resulting 
in the reduction of their tyrosine kinase activity causing 
reduced insulin signaling, and develop insulin resistance. 
Down regulation of protein kinase C activity is an 
important factor in maintaining proper phosphorylation of 
insulin receptors. The insulin resistance was reversed with 
the addition of PKC inhibitors in insulin resistance tissues 
such as fat and skeletal muscles (Itani et al., 2000, Griffin 
et al., 1999, Muller et al., 1991, Maegawa et al., 1991, 
Caro et al., 1987). Low levels of calpain10 have been 
found associated to cholesterol levels, metabolic 
syndrome and polycystic ovary syndrome (Saez et al., 
2007). Therefore increasing the calpain 10a and c level 
carefully, may also reverse the level of protein kinase C 
and hence lowering of insulin resistance or increasing 
insulin sensitivity. Further binding of isoform a with 
phospholipids may lead to better insulin secretion as well. 
Similarity of both isoforms a and c with calpain 9 
indicate its involvement in functions of stomach and small 
intestine as of calpain 9, being exist at both locations in 
humans. Lower expression of calpain 9 is involved in 
developing gastric cancer (Davis et al., 2007). Therefore 
absence of these two isoforms may lead to developing 
similar pathologies in stomach and small intestine. 
However bringing their levels to normal as of healthy 
person may have a therapeutic potential. Therefore by 
increasing the level of these isoforms in stomach may be 
helpful in controlling the diabetes complication of 
stomach. 
 
Structural analysis of Calpain 10g the shortest protein 
showed 26% identity (Sequences from 3-137 amino 
acids) with 1kfxL template which is m-calpain form I and 
II. The m-Calpain form II is typical calpain and is 
involved in cardiovascular disease, acute neurological 
injury, and Alzheimer and cataract formation. Mu-calpain 
is associated with the positive regulation of cell 
proliferation and proteolysis (Randriamboavonjy and 
Fleming 2009). Increased activity of mu calpain due to 
elevated platelet concentration in diabetes result in hyper 
agree ability leading to prothrombotic state (Dean 2010). 
Whereas, m-calpain is known to have association with 
protein auto-processing, responding to hypoxia, 
proteolysis and myoblast fusion. Therefore isoform g 
falling in the twilight zone of homology may play a 
similar but week role in pathogenesis as predicted to 
exhibit protease like activity only because of having 
merely papain-like domain.  
 
Normal expression and function of calpain 10 isoforms 
especially a, and c looks essential for the normal glucose 
metabolism and insulin receptor activation. These 
isoforms belong to the atypical calpain family which does 
not need excessive Ca+2 ions and they require only trace 
amount of calcium for their activity. Therefore at the time 
of low calcium availability, they regulate PKC driven 
insulin receptor activation and their down regulation may 
cause diabetes and may favors the environment of co-
morbid complexity. Calpain-1 and calpain-2 show 
optimal activities when present in a hetrodymeric forms 
with a small subunit of 30 kDa. Structurally calpain 10 is 
less likely to interact with the small subunit because of its 
non hetrodymeric existence. The domain IV of general 
calpains is a calmodulin-like domain that is critical for 
heterodimerization, is absent in calpain10 (Lebovitz 2004, 
Adams and Norwood 2003, Horikawa 2000, Dupree and 
Meyer 1980). Instead there is domain T which makes it 
atypical form of calpain and its function is not known yet. 
Therefore our results raise the possibility that calpain10 
might occur at specific intracellular locations such as 
membrane bound or become functional under specific 
physiological conditions such as oxidative or low 
Bushra Chaudhry et al 
Pak. J. Pharm. Sci., Vol.32, No.3, May 2019, pp.937-946 945





Our data concluded that form a and c have low level 
similarity with m, mu and calpain 9. Therefore these 
isoforms may compensate similar functional activities at 
the time when template levels are down in the cells. The 
presence of C2 like subdomain III of mu-like calpain 
(calpain 2) in calpain 10 isoforms may plays a vibrant role 
in calcium induced activation of their own or other 
proteins. Isoform g, the shortest protein, is predicted of 
having papain-like domain and exhibiting protease like 
activity only. Further carefully addressed in vivo studies 
on animal models or cell lines are required to determine 
predicted mechanism of action of these isoforms. It will 
help to establish the treatment modalities in diabetes and 
its complications by adjusting the levels of calpain 10 
isoforms, because generally caplains over activation has 
been linked to sever diseases which may influence the 
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